iX Biopharma Ltd logo

40V

SGX

iX Biopharma Ltd

Health CareSingapore

Company Overview

Ticker: 40V
Exchange: SGX
Sector: Health Care
Industry: -
Market Cap: -
FY End: June
Employees: -

Alset International Limited, an investment holding company, engages in the property development, investment, food and beverage, biomedical, and direct sales businesses in the United States and Singapore. The company offers robotics consultation and implementation, robot-as-a-service solutions, managed support services, and partnership with robotics developers; land development, home construction, sales, renting, and property management; operating cafes and distributing nutritionally balanced meals; as well as packaging solutions. It also engages in biopharmaceutical technologies to develop treatments in oncology, neurology, and immunology; as well as consumer products, such as natural sugar alternatives, fragrances, insect repellents, antibacterial, antiviral, and antimicrobial technologies. The company was formerly known as Singapore eDevelopment Limited and changed its name to Alset International Limited in September 2020. The company was incorporated in 2009 and is based in Singapore. Alset International Limited is a subsidiary of Alset Business Development Pte. Ltd.

Leadership Team

HF

Executive Chairman & Co-CEO

TM

Co-CEO & Executive Director

WL

Chief Financial Officer

KF

Chief Technology Officer

AH

Senior Vice President of Corporate Affairs

SH

Senior VP of Business Development, Investor Relations Officer & Executive Director

Recent Announcements

No announcements yet.

Price Chart

Insufficient price data

Key Metrics

P/E Ratio-
P/B Ratio1.22
EV/EBITDA-1.64
Dividend Yield-
ROE-25.1%
ROA-15.2%
Net Margin0.0%
Debt/Equity0.01
Net Debt/EBITDA-
FCF Yield-

Governance Score

-

SGX Code of Corporate Governance

StocksSG provides data for informational purposes only. This is not financial advice. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.

Data sources · Full disclaimer